Product Information
EVEROLIMUS 0.75 MG TABLET is a generic product labeled by Biocon Pharma Inc., priced at $5.1927 per EA under NDC 70377007111. Its NADAC has been published 34 times since Nov 5, 2025.
Strength
.75 mg/1
Manufacturer
Biocon Pharma Inc.NDC
70377007111
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EVEROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA216140On Market Since
6/2/2025
Pharmacological Classes
Price Statistics
The NADAC for EVEROLIMUS 0.75 MG TABLET has been published 34 times since Nov 5, 2025, and over the history we have for it it has declined 24.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.1927 per EA |
|---|---|
| All-time high | $8.0069 (Mar 11, 2026) |
| All-time low | $5.1927 (Jun 17, 2026) |
| 52-week high | $8.0069 |
| 52-week low | $5.1927 |
| Median price | $7.2642 |
| Average price | $6.8717 |
| Largest weekly change | -13.9% (Apr 22, 2026) |
| Weeks tracked | 34 |
| Tracking since | Nov 5, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EVEROLIMUS 0.75 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EVEROLIMUS 0.75 MG TABLET, manufactured by Biocon Pharma Inc., is $5.1927 per EA (NDC 70377007111), effective Jun 24, 2026.
How has the price of EVEROLIMUS 0.75 MG TABLET changed over time?
Over the history we have for it, the NADAC for EVEROLIMUS 0.75 MG TABLET has declined 24.2%. It has been tracked across 34 weekly CMS publications since Nov 5, 2025.
What are the highest and lowest recorded NADAC prices for EVEROLIMUS 0.75 MG TABLET?
Since Nov 5, 2025, the NADAC for EVEROLIMUS 0.75 MG TABLET has ranged from a low of $5.1927 (Jun 17, 2026) to a high of $8.0069 (Mar 11, 2026), with a median of $7.2642 per EA.
Are there cheaper alternatives to EVEROLIMUS 0.75 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as EVEROLIMUS 0.75 MG TABLET, but none are currently priced below it.
Who manufactures EVEROLIMUS 0.75 MG TABLET?
EVEROLIMUS 0.75 MG TABLET (NDC 70377007111) is labeled by Biocon Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification